0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Newborn Genetic Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-17X13366
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Newborn Genetic Screening Market Research Report 2023
BUY CHAPTERS

Newborn Genetic Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-17X13366
Report
October 2024
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Newborn Genetic Screening - Market Size

The global market for Newborn Genetic Screening was estimated to be worth US$ 104 million in 2023 and is forecast to a readjusted size of US$ 223.4 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030

Newborn Genetic Screening - Market

Newborn Genetic Screening - Market

Newborn Genetic Screening involves testing newborns shortly after birth to identify genetic and metabolic disorders that might not be apparent at birth but can be treated or managed if detected early.
Public health initiatives, parental awareness, and advancements in medical genetics contribute to the widespread adoption of newborn genetic screening programs, promoting early intervention and improved outcomes.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Newborn Genetic Screening, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Newborn Genetic Screening by region & country, by Type, and by Application.
The Newborn Genetic Screening market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Genetic Screening.
Market Segmentation

Scope of Newborn Genetic Screening - Market Report

Report Metric Details
Report Name Newborn Genetic Screening - Market
Forecasted market size in 2030 US$ 223.4 million
CAGR 3.1%
Forecasted years 2024 - 2030
Segment by Type:
  • Dry blood spot tests
  • Hearing screening tests
  • CCHD screening tests
Segment by Application
  • Clinical Laboratories
  • Hospitals
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Trivitron Healthcare, MASIMO CORPORATION, Covidien Plc, Nemours KidsHealth, NJ.gov, Agilent Technologies, Ge Healthcare, PERKINELMER, Natus Medical Incorporated, Waters, Bio-Rad Laboratories, Ab Sciex LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Newborn Genetic Screening manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Newborn Genetic Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Newborn Genetic Screening in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Newborn Genetic Screening - Market size in 2030?

Ans: The Newborn Genetic Screening - Market size in 2030 will be US$ 223.4 million.

Who are the main players in the Newborn Genetic Screening - Market report?

Ans: The main players in the Newborn Genetic Screening - Market are Trivitron Healthcare, MASIMO CORPORATION, Covidien Plc, Nemours KidsHealth, NJ.gov, Agilent Technologies, Ge Healthcare, PERKINELMER, Natus Medical Incorporated, Waters, Bio-Rad Laboratories, Ab Sciex LLC

What are the Application segmentation covered in the Newborn Genetic Screening - Market report?

Ans: The Applications covered in the Newborn Genetic Screening - Market report are Clinical Laboratories, Hospitals

What are the Type segmentation covered in the Newborn Genetic Screening - Market report?

Ans: The Types covered in the Newborn Genetic Screening - Market report are Dry blood spot tests, Hearing screening tests, CCHD screening tests

1 Market Overview
1.1 Newborn Genetic Screening Product Introduction
1.2 Global Newborn Genetic Screening Market Size Forecast
1.3 Newborn Genetic Screening Market Trends & Drivers
1.3.1 Newborn Genetic Screening Industry Trends
1.3.2 Newborn Genetic Screening Market Drivers & Opportunity
1.3.3 Newborn Genetic Screening Market Challenges
1.3.4 Newborn Genetic Screening Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Newborn Genetic Screening Players Revenue Ranking (2023)
2.2 Global Newborn Genetic Screening Revenue by Company (2019-2024)
2.3 Key Companies Newborn Genetic Screening Manufacturing Base Distribution and Headquarters
2.4 Key Companies Newborn Genetic Screening Product Offered
2.5 Key Companies Time to Begin Mass Production of Newborn Genetic Screening
2.6 Newborn Genetic Screening Market Competitive Analysis
2.6.1 Newborn Genetic Screening Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Newborn Genetic Screening Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Genetic Screening as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dry blood spot tests
3.1.2 Hearing screening tests
3.1.3 CCHD screening tests
3.2 Global Newborn Genetic Screening Sales Value by Type
3.2.1 Global Newborn Genetic Screening Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Newborn Genetic Screening Sales Value, by Type (2019-2030)
3.2.3 Global Newborn Genetic Screening Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinical Laboratories
4.1.2 Hospitals
4.2 Global Newborn Genetic Screening Sales Value by Application
4.2.1 Global Newborn Genetic Screening Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Newborn Genetic Screening Sales Value, by Application (2019-2030)
4.2.3 Global Newborn Genetic Screening Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Newborn Genetic Screening Sales Value by Region
5.1.1 Global Newborn Genetic Screening Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Newborn Genetic Screening Sales Value by Region (2019-2024)
5.1.3 Global Newborn Genetic Screening Sales Value by Region (2025-2030)
5.1.4 Global Newborn Genetic Screening Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Newborn Genetic Screening Sales Value, 2019-2030
5.2.2 North America Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Newborn Genetic Screening Sales Value, 2019-2030
5.3.2 Europe Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Newborn Genetic Screening Sales Value, 2019-2030
5.4.2 Asia Pacific Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Newborn Genetic Screening Sales Value, 2019-2030
5.5.2 South America Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Newborn Genetic Screening Sales Value, 2019-2030
5.6.2 Middle East & Africa Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Newborn Genetic Screening Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Newborn Genetic Screening Sales Value
6.3 United States
6.3.1 United States Newborn Genetic Screening Sales Value, 2019-2030
6.3.2 United States Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Newborn Genetic Screening Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Newborn Genetic Screening Sales Value, 2019-2030
6.4.2 Europe Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Newborn Genetic Screening Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Newborn Genetic Screening Sales Value, 2019-2030
6.5.2 China Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
6.5.3 China Newborn Genetic Screening Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Newborn Genetic Screening Sales Value, 2019-2030
6.6.2 Japan Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Newborn Genetic Screening Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Newborn Genetic Screening Sales Value, 2019-2030
6.7.2 South Korea Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Newborn Genetic Screening Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Newborn Genetic Screening Sales Value, 2019-2030
6.8.2 Southeast Asia Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Newborn Genetic Screening Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Newborn Genetic Screening Sales Value, 2019-2030
6.9.2 India Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
6.9.3 India Newborn Genetic Screening Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Trivitron Healthcare
7.1.1 Trivitron Healthcare Profile
7.1.2 Trivitron Healthcare Main Business
7.1.3 Trivitron Healthcare Newborn Genetic Screening Products, Services and Solutions
7.1.4 Trivitron Healthcare Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.1.5 Trivitron Healthcare Recent Developments
7.2 MASIMO CORPORATION
7.2.1 MASIMO CORPORATION Profile
7.2.2 MASIMO CORPORATION Main Business
7.2.3 MASIMO CORPORATION Newborn Genetic Screening Products, Services and Solutions
7.2.4 MASIMO CORPORATION Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.2.5 MASIMO CORPORATION Recent Developments
7.3 Covidien Plc
7.3.1 Covidien Plc Profile
7.3.2 Covidien Plc Main Business
7.3.3 Covidien Plc Newborn Genetic Screening Products, Services and Solutions
7.3.4 Covidien Plc Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.3.5 Nemours KidsHealth Recent Developments
7.4 Nemours KidsHealth
7.4.1 Nemours KidsHealth Profile
7.4.2 Nemours KidsHealth Main Business
7.4.3 Nemours KidsHealth Newborn Genetic Screening Products, Services and Solutions
7.4.4 Nemours KidsHealth Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.4.5 Nemours KidsHealth Recent Developments
7.5 NJ.gov
7.5.1 NJ.gov Profile
7.5.2 NJ.gov Main Business
7.5.3 NJ.gov Newborn Genetic Screening Products, Services and Solutions
7.5.4 NJ.gov Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.5.5 NJ.gov Recent Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Profile
7.6.2 Agilent Technologies Main Business
7.6.3 Agilent Technologies Newborn Genetic Screening Products, Services and Solutions
7.6.4 Agilent Technologies Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.6.5 Agilent Technologies Recent Developments
7.7 Ge Healthcare
7.7.1 Ge Healthcare Profile
7.7.2 Ge Healthcare Main Business
7.7.3 Ge Healthcare Newborn Genetic Screening Products, Services and Solutions
7.7.4 Ge Healthcare Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.7.5 Ge Healthcare Recent Developments
7.8 PERKINELMER
7.8.1 PERKINELMER Profile
7.8.2 PERKINELMER Main Business
7.8.3 PERKINELMER Newborn Genetic Screening Products, Services and Solutions
7.8.4 PERKINELMER Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.8.5 PERKINELMER Recent Developments
7.9 Natus Medical Incorporated
7.9.1 Natus Medical Incorporated Profile
7.9.2 Natus Medical Incorporated Main Business
7.9.3 Natus Medical Incorporated Newborn Genetic Screening Products, Services and Solutions
7.9.4 Natus Medical Incorporated Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.9.5 Natus Medical Incorporated Recent Developments
7.10 Waters
7.10.1 Waters Profile
7.10.2 Waters Main Business
7.10.3 Waters Newborn Genetic Screening Products, Services and Solutions
7.10.4 Waters Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.10.5 Waters Recent Developments
7.11 Bio-Rad Laboratories
7.11.1 Bio-Rad Laboratories Profile
7.11.2 Bio-Rad Laboratories Main Business
7.11.3 Bio-Rad Laboratories Newborn Genetic Screening Products, Services and Solutions
7.11.4 Bio-Rad Laboratories Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.11.5 Bio-Rad Laboratories Recent Developments
7.12 Ab Sciex LLC
7.12.1 Ab Sciex LLC Profile
7.12.2 Ab Sciex LLC Main Business
7.12.3 Ab Sciex LLC Newborn Genetic Screening Products, Services and Solutions
7.12.4 Ab Sciex LLC Newborn Genetic Screening Revenue (US$ Million) & (2019-2024)
7.12.5 Ab Sciex LLC Recent Developments
8 Industry Chain Analysis
8.1 Newborn Genetic Screening Industrial Chain
8.2 Newborn Genetic Screening Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Newborn Genetic Screening Sales Model
8.5.2 Sales Channel
8.5.3 Newborn Genetic Screening Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Newborn Genetic Screening Market Trends
    Table 2. Newborn Genetic Screening Market Drivers & Opportunity
    Table 3. Newborn Genetic Screening Market Challenges
    Table 4. Newborn Genetic Screening Market Restraints
    Table 5. Global Newborn Genetic Screening Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Newborn Genetic Screening Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Newborn Genetic Screening Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Newborn Genetic Screening Product Type
    Table 9. Key Companies Time to Begin Mass Production of Newborn Genetic Screening
    Table 10. Global Newborn Genetic Screening Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Genetic Screening as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Newborn Genetic Screening Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Newborn Genetic Screening Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Newborn Genetic Screening Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Newborn Genetic Screening Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Newborn Genetic Screening Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Newborn Genetic Screening Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Newborn Genetic Screening Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Newborn Genetic Screening Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Newborn Genetic Screening Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Newborn Genetic Screening Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Newborn Genetic Screening Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Newborn Genetic Screening Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Newborn Genetic Screening Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Newborn Genetic Screening Sales Value by Region (2019-2024) & (%)
    Table 27. Global Newborn Genetic Screening Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Newborn Genetic Screening Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Newborn Genetic Screening Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Newborn Genetic Screening Sales Value, (2025-2030) & (US$ Million)
    Table 31. Trivitron Healthcare Basic Information List
    Table 32. Trivitron Healthcare Description and Business Overview
    Table 33. Trivitron Healthcare Newborn Genetic Screening Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Newborn Genetic Screening Business of Trivitron Healthcare (2019-2024)
    Table 35. Trivitron Healthcare Recent Developments
    Table 36. MASIMO CORPORATION Basic Information List
    Table 37. MASIMO CORPORATION Description and Business Overview
    Table 38. MASIMO CORPORATION Newborn Genetic Screening Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Newborn Genetic Screening Business of MASIMO CORPORATION (2019-2024)
    Table 40. MASIMO CORPORATION Recent Developments
    Table 41. Covidien Plc Basic Information List
    Table 42. Covidien Plc Description and Business Overview
    Table 43. Covidien Plc Newborn Genetic Screening Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Newborn Genetic Screening Business of Covidien Plc (2019-2024)
    Table 45. Covidien Plc Recent Developments
    Table 46. Nemours KidsHealth Basic Information List
    Table 47. Nemours KidsHealth Description and Business Overview
    Table 48. Nemours KidsHealth Newborn Genetic Screening Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Newborn Genetic Screening Business of Nemours KidsHealth (2019-2024)
    Table 50. Nemours KidsHealth Recent Developments
    Table 51. NJ.gov Basic Information List
    Table 52. NJ.gov Description and Business Overview
    Table 53. NJ.gov Newborn Genetic Screening Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Newborn Genetic Screening Business of NJ.gov (2019-2024)
    Table 55. NJ.gov Recent Developments
    Table 56. Agilent Technologies Basic Information List
    Table 57. Agilent Technologies Description and Business Overview
    Table 58. Agilent Technologies Newborn Genetic Screening Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Newborn Genetic Screening Business of Agilent Technologies (2019-2024)
    Table 60. Agilent Technologies Recent Developments
    Table 61. Ge Healthcare Basic Information List
    Table 62. Ge Healthcare Description and Business Overview
    Table 63. Ge Healthcare Newborn Genetic Screening Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Newborn Genetic Screening Business of Ge Healthcare (2019-2024)
    Table 65. Ge Healthcare Recent Developments
    Table 66. PERKINELMER Basic Information List
    Table 67. PERKINELMER Description and Business Overview
    Table 68. PERKINELMER Newborn Genetic Screening Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Newborn Genetic Screening Business of PERKINELMER (2019-2024)
    Table 70. PERKINELMER Recent Developments
    Table 71. Natus Medical Incorporated Basic Information List
    Table 72. Natus Medical Incorporated Description and Business Overview
    Table 73. Natus Medical Incorporated Newborn Genetic Screening Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Newborn Genetic Screening Business of Natus Medical Incorporated (2019-2024)
    Table 75. Natus Medical Incorporated Recent Developments
    Table 76. Waters Basic Information List
    Table 77. Waters Description and Business Overview
    Table 78. Waters Newborn Genetic Screening Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Newborn Genetic Screening Business of Waters (2019-2024)
    Table 80. Waters Recent Developments
    Table 81. Bio-Rad Laboratories Basic Information List
    Table 82. Bio-Rad Laboratories Description and Business Overview
    Table 83. Bio-Rad Laboratories Newborn Genetic Screening Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Newborn Genetic Screening Business of Bio-Rad Laboratories (2019-2024)
    Table 85. Bio-Rad Laboratories Recent Developments
    Table 86. Ab Sciex LLC Basic Information List
    Table 87. Ab Sciex LLC Description and Business Overview
    Table 88. Ab Sciex LLC Newborn Genetic Screening Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Newborn Genetic Screening Business of Ab Sciex LLC (2019-2024)
    Table 90. Ab Sciex LLC Recent Developments
    Table 91. Key Raw Materials Lists
    Table 92. Raw Materials Key Suppliers Lists
    Table 93. Newborn Genetic Screening Downstream Customers
    Table 94. Newborn Genetic Screening Distributors List
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
    Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Newborn Genetic Screening Product Picture
    Figure 2. Global Newborn Genetic Screening Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Newborn Genetic Screening Sales Value (2019-2030) & (US$ Million)
    Figure 4. Newborn Genetic Screening Report Years Considered
    Figure 5. Global Newborn Genetic Screening Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Newborn Genetic Screening Revenue in 2023
    Figure 7. Newborn Genetic Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Dry blood spot tests Picture
    Figure 9. Hearing screening tests Picture
    Figure 10. CCHD screening tests Picture
    Figure 11. Global Newborn Genetic Screening Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Newborn Genetic Screening Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Clinical Laboratories
    Figure 14. Product Picture of Hospitals
    Figure 15. Global Newborn Genetic Screening Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Newborn Genetic Screening Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Newborn Genetic Screening Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Newborn Genetic Screening Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Newborn Genetic Screening Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Newborn Genetic Screening Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Newborn Genetic Screening Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Newborn Genetic Screening Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Newborn Genetic Screening Sales Value (%), (2019-2030)
    Figure 28. United States Newborn Genetic Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Newborn Genetic Screening Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Newborn Genetic Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Newborn Genetic Screening Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Newborn Genetic Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Newborn Genetic Screening Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Newborn Genetic Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Newborn Genetic Screening Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Newborn Genetic Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Newborn Genetic Screening Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Newborn Genetic Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Newborn Genetic Screening Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Newborn Genetic Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Newborn Genetic Screening Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Newborn Genetic Screening Sales Value by Application (%), 2023 VS 2030
    Figure 49. Newborn Genetic Screening Industrial Chain
    Figure 50. Newborn Genetic Screening Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS